Literature DB >> 22094203

Non-pharmacological treatment of chronic widespread musculoskeletal pain.

Afton L Hassett1, David A Williams.   

Abstract

Individuals with chronic widespread pain, including those with fibromyalgia, pose a particular challenge to treatment, given the modest effectiveness of pharmacological agents for this condition. The growing consensus indicates that the best approach to treatment involves the combination of pharmacological and non-pharmacological interventions. Several non-pharmacological interventions, particularly exercise and cognitive-behavioural therapy (CBT), have garnered good evidence of effectiveness as stand-alone, adjunctive treatments for patients with chronic pain. In this article, evidenced-based, non-pharmacological management techniques for chronic widespread pain are described by using two broad categories, exercise and CBT. The evidence for decreasing pain, improving functioning and changing secondary symptoms is highlighted. Lastly, the methods by which exercise and CBT can be combined for a multi-component approach, which is consistent with the current evidence-based guidelines of several American and European medical societies, are addressed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22094203     DOI: 10.1016/j.berh.2011.01.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  21 in total

1.  Physical activity and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Ran Zhang; Andrea K Chomistek; Jordan D Dimitrakoff; Edward L Giovannucci; Walter C Willett; Bernard A Rosner; Kana Wu
Journal:  Med Sci Sports Exerc       Date:  2015-04       Impact factor: 5.411

2.  Psychosocial co-morbidities in Interstitial Cystitis/Bladder Pain syndrome (IC/BPS): A systematic review.

Authors:  Lindsey C McKernan; Colin G Walsh; William S Reynolds; Leslie J Crofford; Roger R Dmochowski; David A Williams
Journal:  Neurourol Urodyn       Date:  2017-10-09       Impact factor: 2.696

Review 3.  Pain and depression: an integrative review of neurobiological and psychological factors.

Authors:  Jenna Goesling; Daniel J Clauw; Afton L Hassett
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  PROMIS Physical and Emotional Health Scores Are Worse in Musculoskeletal Patients Presenting to Physiatrists than to Other Orthopedic Specialists.

Authors:  Abby L Cheng; Ryan Calfee; Graham Colditz; Heidi Prather
Journal:  PM R       Date:  2019-03-25       Impact factor: 2.298

5.  Combining cognitive-behavioral therapy and milnacipran for fibromyalgia: a feasibility randomized-controlled trial.

Authors:  Dennis C Ang; Mark P Jensen; Jennifer L Steiner; Janna Hilligoss; Richard H Gracely; Chandan Saha
Journal:  Clin J Pain       Date:  2013-09       Impact factor: 3.442

Review 6.  Cognitive impairment in fibromyalgia.

Authors:  Paulo Henrique Ferreira Bertolucci; Fabricio Ferreira de Oliveira
Journal:  Curr Pain Headache Rep       Date:  2013-07

7.  Biopsychosocial typologies of pain in a cohort of patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Shervin Assassi; Deepthi K Nair; Tiffany A Graham; Brayden P Yellman; Rosa M Estrada-Y-Martin; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

Review 8.  Physical exercise as non-pharmacological treatment of chronic pain: Why and when.

Authors:  Kirsten R Ambrose; Yvonne M Golightly
Journal:  Best Pract Res Clin Rheumatol       Date:  2015-05-23       Impact factor: 4.098

Review 9.  The Role of Resilience in the Clinical Management of Chronic Pain.

Authors:  Afton L Hassett; Patrick H Finan
Journal:  Curr Pain Headache Rep       Date:  2016-06

10.  Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients.

Authors:  Lorenzo Bettoni; Felice Giulio Bonomi; Viviana Zani; Luigia Manisco; Annamaria Indelicato; Patrizia Lanteri; Giuseppe Banfi; Giovanni Lombardi
Journal:  Clin Rheumatol       Date:  2013-05-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.